These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 31277986)
1. Estimation of the hepatitis E assay-dependent seroprevalence among Croatian blood donors. Miletić M; Vuk T; Hećimović A; Stojić Vidović M; Jemeršić L; Jukić I Transfus Clin Biol; 2019 Nov; 26(4):229-233. PubMed ID: 31277986 [TBL] [Abstract][Full Text] [Related]
2. Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors. Al-Absi ES; Al-Sadeq DW; Younis MH; Yassine HM; Abdalla OM; Mesleh AG; Hadwan TA; Amimo JO; Thalib L; Nasrallah GK J Med Microbiol; 2018 Sep; 67(9):1302-1309. PubMed ID: 30051802 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis E virus infection in Hong Kong blood donors. Tsoi WC; Zhu X; To AP; Holmberg J Vox Sang; 2020 Jan; 115(1):11-17. PubMed ID: 31709559 [TBL] [Abstract][Full Text] [Related]
4. HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kits. Yaşar O; Karatayli E; Cengiz G; Kızılpınar M; Yurdcu E; Albayrak R; Güven A; Arslan Ö; Karahan C; Otlu B; Güdücüoğlu H; Gökahmetoğlu S; Berk E; Kirişci Ö; Sertöz R; Yurdaydin C; Bozdayi AM; Karatayli SC J Med Virol; 2019 Dec; 91(12):2174-2181. PubMed ID: 31403185 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis E virus seroprevalence among blood donors in Pune, India. Tripathy AS; Puranik S; Sharma M; Chakraborty S; Devakate UR J Med Virol; 2019 May; 91(5):813-819. PubMed ID: 30489644 [TBL] [Abstract][Full Text] [Related]
6. Course of HEV viremia and anti-HEV IgM/IgG response in asymptomatic blood donors. Kraef C; Schlein C; Hiller J; Westhölter D; Denzer U; Horvatits T; Peine S; Lohse AW; Lütgehetmann M; Polywka S; Pischke S J Clin Virol; 2018 Aug; 105():26-30. PubMed ID: 29860111 [TBL] [Abstract][Full Text] [Related]
7. [Investigation of the hepatitis E virus seroprevalence in cases admitted to Hacettepe University Medical Faculty Hospital]. Aydın NN; Ergünay K; Karagül A; Pınar A; Us D Mikrobiyol Bul; 2015 Oct; 49(4):554-64. PubMed ID: 26649413 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. Lin CC; Wu JC; Chang TT; Chang WY; Yu ML; Tam AW; Wang SC; Huang YH; Chang FY; Lee SD J Clin Microbiol; 2000 Nov; 38(11):3915-8. PubMed ID: 11060044 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis E virus seroprevalence in Polish soldiers serving in harsh environmental conditions. Korzeniewski K; Osińska J; Korsak J; Konior M Int Marit Health; 2018; 69(2):137-141. PubMed ID: 29939391 [TBL] [Abstract][Full Text] [Related]
11. Monitoring of Anti-Hepatitis E Virus Antibody Seroconversion in Asymptomatically Infected Blood Donors: Systematic Comparison of Nine Commercial Anti-HEV IgM and IgG Assays. Vollmer T; Diekmann J; Eberhardt M; Knabbe C; Dreier J Viruses; 2016 Aug; 8(8):. PubMed ID: 27556482 [TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of hepatitis E in patients on haemodialysis in Croatia. Mrzljak A; Dinjar-Kujundzic P; Knotek M; Kudumija B; Ilic M; Gulin M; Zibar L; Hrstic I; Jurekovic Z; Kolaric B; Jemersic L; Prpic J; Tomljenovic M; Vilibic-Cavlek T Int Urol Nephrol; 2020 Feb; 52(2):371-378. PubMed ID: 31894559 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence and Incidence of hepatitis E in blood donors in Upper Austria. Fischer C; Hofmann M; Danzer M; Hofer K; Kaar J; Gabriel C PLoS One; 2015; 10(3):e0119576. PubMed ID: 25751574 [TBL] [Abstract][Full Text] [Related]
14. Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016. Niederhauser C; Widmer N; Hotz M; Tinguely C; Fontana S; Allemann G; Borri M; Infanti L; Sarraj A; Sigle J; Stalder M; Thierbach J; Waldvogel S; Wiengand T; Züger M; Gowland P Euro Surveill; 2018 Aug; 23(35):. PubMed ID: 30180927 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis E seroprevalence and associated risk factors in Croatian liver transplant recipients. Mrzljak A; Dinjar-Kujundzic P; Vilibic-Cavlek T; Jemersic L; Prpic J; Dakovic-Rode O; Kolaric B; Vince A Rev Soc Bras Med Trop; 2019; 52():e20190302. PubMed ID: 31618309 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014. Lucarelli C; Spada E; Taliani G; Chionne P; Madonna E; Marcantonio C; Pezzotti P; Bruni R; La Rosa G; Pisani G; Dell'Orso L; Ragone K; Tomei C; Ciccaglione AR Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494608 [TBL] [Abstract][Full Text] [Related]
17. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. Rossi-Tamisier M; Moal V; Gerolami R; Colson P J Clin Virol; 2013 Jan; 56(1):62-4. PubMed ID: 23089569 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India. Katiyar H; Goel A; Sonker A; Yadav V; Sapun S; Chaudhary R; Aggarwal R Indian J Gastroenterol; 2018 Jul; 37(4):342-346. PubMed ID: 30159666 [TBL] [Abstract][Full Text] [Related]
19. [The prevalence of antibodies against Hepatitis E Virus in the Czech Republic: serological survey]. Němeček V; Butovičová P; Malý M; Dítě P; Veřtátová M; Vodičková I; Kříž B Epidemiol Mikrobiol Imunol; 2017; 66(1):3-7. PubMed ID: 28374592 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis E virus (HEV) antibodies in Serbian blood donors. Petrović T; Lupulović D; Jiménez de Oya N; Vojvodić S; Blázquez AB; Escribano-Romero E; Martín-Acebes MA; Potkonjak A; Milošević V; Lazić S; Saiz JC J Infect Dev Ctries; 2014 Oct; 8(10):1322-7. PubMed ID: 25313610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]